Stifel Financial
NAUT icon

Stifel Financial’s Nautilus Biotechnolgy NAUT Stock Holding History

Stifel Financial’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-13,063
Closed -$50.6K – 3366
2023
Q2 		$50.6K Sell
13,063
-807
-6% -$2.33K ﹤0.01% 3237
2023
Q1 		$38.4K Sell
13,870
-587
-4% -$1.23K ﹤0.01% 3252
2022
Q4 		$26K Sell
14,457
-4,995
-26% -$9.64K ﹤0.01% 3232
2022
Q3 		$41K Buy
19,452
+4,596
+31% +$11.6K ﹤0.01% 3193
2022
Q2 		$40K Sell
14,856
-3,000
-17% -$11.2K ﹤0.01% 3244
2022
Q1 		$77K Buy
17,856
+6,000
+51% +$24.6K ﹤0.01% 3277
2021
Q4 		$61K Buy
11,856
+1,045
+10% +$5.59K ﹤0.01% 3298
2021
Q3 		$66K Buy
+10,811
New +$86.1K ﹤0.01% 3264

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $473M AUM 49.24% 1-Year Est. Return
AEPLI
AH Equity Partners LSV II Menlo Park, California $95.6M AUM 8.86% 1-Year Est. Return

Stifel Financial's NAUT Position: Q3 2023 in Review

Stifel Financial sold out of Nautilus Biotechnolgy (NAUT) in Q3 2023, closing a stake of 13,063 shares — an estimated $50.6K sold.

Stifel Financial first reported a position in NAUT in Q3 2021 and held it in 8 quarters. The position peaked at $77K in Q1 2022. 75 funds tracked by Wall St. Rank hold NAUT as of Q3 2023.

  • Stifel Financial reported no remaining Nautilus Biotechnolgy position as of Q3 2023 after selling out during the quarter.
  • Stifel Financial sold 13,063 Nautilus Biotechnolgy shares in Q3 2023, an estimated $50.6K.
  • Stifel Financial first reported a position in Nautilus Biotechnolgy in Q3 2021 and held it in 8 quarters.
  • Stifel Financial's Nautilus Biotechnolgy position peaked at $77K in Q1 2022.
  • 75 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q3 2023.

Based on Stifel Financial's 13F filing for Q3 2023, filed 13 Nov 2023.